fusigen has been researched along with arginyl-glycyl-aspartic acid in 2 studies
| Studies (fusigen) | Trials (fusigen) | Recent Studies (post-2010) (fusigen) | Studies (arginyl-glycyl-aspartic acid) | Trials (arginyl-glycyl-aspartic acid) | Recent Studies (post-2010) (arginyl-glycyl-aspartic acid) |
|---|---|---|---|---|---|
| 23 | 0 | 16 | 4,556 | 17 | 1,799 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Decristoforo, C; Franssen, GM; Haas, H; Haubner, R; Laverman, P; Petrik, M; Rangger, C; Summer, D; Zhai, C | 2 |
2 other study(ies) available for fusigen and arginyl-glycyl-aspartic acid
| Article | Year |
|---|---|
Novel Bifunctional Cyclic Chelator for (89)Zr Labeling-Radiolabeling and Targeting Properties of RGD Conjugates.
Topics: Chelating Agents; Ferric Compounds; Humans; Hydroxamic Acids; Oligopeptides; Positron-Emission Tomography; Radioisotopes; Zirconium | 2015 |
Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [(68)Ga]NODAGA-RGD-In Vivo Imaging Studies in Human Xenograft Tumors.
Topics: Acetates; Animals; Cell Line, Tumor; Endocytosis; Female; Ferric Compounds; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Hydroxamic Acids; Imaging, Three-Dimensional; Melanoma; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tissue Distribution; Xenograft Model Antitumor Assays | 2016 |